We evaluated the accuracy of heat-denatured, amplification-boosted ultrasensitive p24 assay (Up24) compared with reverse transcriptase polymerase chain reaction (RT-PCR). We tested 394 samples from Ugandans infected with HIV-1 non-B subtypes. We compared Up24 levels (HIV-1 p24 Core Profile enzyme-linked immunosorbent assay (ELISA), NEN Life Science Products) to RNA viral loads (Amplicor HIV-1 Monitor 1.5, Roche) by linear regression, and calculated sensitivity, specificity, positive and negative predictive values. Median viral load was 4.9 log10 copies/mL (interquartile range [IQR], 2.6–5.5); 114 samples (29%) were undetectable (500,000, 250,000–500,000, 100,000–250,000, 50,000–100,000 and 400–50,000 copies/mL, respectively. In conclusion, when compared with RT-PCR for patients infected with non-B subtypes, the Up24 demonstrated limited sensitivity especially at low viral loads. Moreover, the Up24 was positive in 33% of samples deemed undetectable by RT-PCR, which may limit the use of the Up24 to detect viral suppression.
HammerSM, EronJJJr, ReissP. Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society, USA panel.JAMA2008; 300: 555–70
SchupbachJ, TomasikZ, KnuchelM. Optimized virus disruption improves detection of HIV-1 p24 in particles and uncovers a p24 reactivity in patients with undetectable HIV-1 RNA under long-term HAART.J Med Virol2006; 78: 1003–10
4.
LedergerberB, FleppM, BoniJ. Human immunodeficiency virus type 1 p24 concentration measured by boosted ELISA of heat-denatured plasma correlates with decline in CD4 cells, progression to AIDS, and survival: comparison with viral RNA measurement.J Infect Dis2000; 181: 1280–8
5.
SterlingTR, HooverDR, AstemborskiJ. Heat-denatured human immunodeficiency virus type 1 protein 24 antigen: prognostic value in adults with early-stage disease.J Infect Dis2002; 186: 1181–5
6.
BoniJ, OpravilM, TomasikZ. Simple monitoring of antiretroviral therapy with a signal-amplification-boosted HIV-1 p24 antigen assay with heat-denatured plasma.AIDS1997; 11: F47–F52
7.
RespessRA, CachafeiroA, WithumD. Evaluation of an ultrasensitive p24 antigen assay as a potential alternative to human immunodeficiency virus type 1 RNA viral load assay in resource-limited settings.J Clin Microbiol2005; 43: 506–8
8.
SchupbachJ, BoniJ, FleppM. Antiretroviral treatment monitoring with an improved HIV-1 p24 antigen test: an inexpensive alternative to tests for viral RNA.j Med Virol2001; 65: 225–32
9.
SchupbachJ, GunthardH, JoosB. HIV-1 p24 may persist during long-term highly active antiretroviral therapy, increases little during short treatment breaks, and its rebound after treatment stop correlates with CD4+ T cell loss.J Acquir Immune Defic Syndr2005; 40: 250–6
10.
ErikstrupC, KallestrupP, Zinyama-GutsireRB. p24 as a predictor of mortality in a cohort of HIV-1-infected adults in rural Africa.J Acquir Immune Defic Syndr2008; 48: 345–9
11.
SpacekLA, HensonC, GrayRH. Evaluation of heat-denatured HIV-1 p24 antigen as an alternative, inexpensive marker for HIV-1 RNA viral load in non-B HIV-1 subtypes in sub-Saharan Africa. 10th Conference on Retroviruses and Opportunistic Infections. 2003
12.
StevensG, RekhviashviliN, ScottLE, GoninR, StevensW. Evaluation of two commercially available, inexpensive alternative assays used for assessing viral load in a cohort of human immunodeficiency virus type 1 subtype C-infected patients from South Africa.J Clin Microbiol2005; 43: 857–61
13.
PascualA, CachafeiroA, FunkML, FiscusSA. Comparison of an assay using signal amplification of the heat-dissociated p24 antigen with the Roche Monitor human immunodeficiency virus RNA assay.J Clin Microbiol2002; 40: 2472–5
14.
BonardD, RouetF, ToniTA. Field evaluation of an improved assay using a heat-dissociated p24 antigen for adults mainly infected with HIV-1 CRF02_AG strains in Cote d'Ivoire, West Africa.J Acquir Immune Defic Syndr2003; 34: 267–73
15.
LombartJP, VrayM, KafandoA. Plasma virion reverse transcriptase activity and heat dissociation-boosted p24 assay for HIV load in Burkina Faso, West Africa.AIDS2005; 19: 1273–7
16.
OndoaP, DieyeTN, VereeckenC. Evaluation of HIV-1 p24 antigenemia and level of CD8+CD38+ T cells as surrogate markers of HIV-1 RNA viral load in HIV-1-infected patients in Dakar, Senegal.J Acquit Immune Defic Syndr2006; 41: 416–24
17.
GuayLA, HornDL, KabengeraSR. HIV-1 ICD p24 antigen detection in Ugandan infants: use in early diagnosis of infection and as a marker of disease progression.J Med Virol2000; 62: 426–34
18.
LyamuyaE, Bredberg-RadenU, MassaweA. Performance of a modified HIV-1 p24 antigen assay for early diagnosis of HIV-1 infection in infants and prediction of mother-to-infant transmission of HIV-1 in Dar es Salaam, Tanzania.J Acquit Immune Defic Syndr Hum Retrovirol1996; 12: 421–6
19.
De BaetsAJ, EdidiBS, KasaliMJ. Pediatric human immunodeficiency virus screening in an African district hospital.Clin Diagn Lab Immunol2005; 12: 86–92
20.
FiscusSA, PilcherCD, MillerWC. Rapid, real-time detection of acute HIV infection in patients in Africa.J Infect Dis2007; 195: 416–24
21.
HerbeckJT, LyagobaF, MooreSW. Prevalence and genetic diversity of HIV type 1 subtypes A and D in women attending antenatal clinics in Uganda.AIDS Res Hum Retroviruses2007; 23: 755–60
22.
KamyaMR, Mayanja-KizzaH, KambuguA. Predictors of long-term viral failure among Ugandan children and adults treated with antiretroviral therapy.J Acquir Immune Defic Syndr2007; 46: 187–93
23.
SchockmelGA, YerlyS, PerrinL. Detection of low HIV-1 RNA levels in plasma.J Acquir Immune Defic Syndr Hum Retrovirol1997; 14: 179–83
24.
SchupbachJ, BoniJ, BissetLR. HIV-1 p24 antigen is a significant inverse correlate of CD4T-cell change in patients with suppressed viremia under long-term antiretroviral therapy.J Acquir Immune Defic Syndr2003; 33: 292–9
25.
SchupbachJ, FleppM, PontelliD, TomasikZ, LuthyR, BoniJ. Heat-mediated immune complex dissociation and enzyme-linked immunosorbent assay signal amplification render p24 antigen detection in plasma as sensitive as HIV-1 RNA detection by polymerase chain reaction.AIDS1996; 10: 1085–90
26.
RibasSG, OndoaP, SchupbachJ, van derGG, FransenK. Performance of a quantitative human immunodeficiency virus type 1 p24 antigen assay on various HIV-1 subtypes for the follow-up of human immunodeficiency type 1 seropositive individuals.J Virol Methods2003; 113: 29–34
27.
KimEY, StantonJ, KorberBT. Detection of HIV-1 p24 Gag in plasma by a nanoparticle-based bio-barcode-amplification method.Nanomedicine2008; 3: 293–303
28.
TangS, ZhaoJ, StorhoffJJ. Nanoparticle-based biobarcode amplification assay (BCA) for sensitive and early detection of human immunodeficiency type 1 capsid (p24) antigen.J Acquir Immune Defic Syndr2007; 46: 231–7
29.
JenningsC, FiscusSA, CroweSM. Comparison of two human immunodeficiency virus (HIV) RNA surrogate assays to the standard HIV RNA assay.J Clin Microbiol2005; 43: 5950–6
30.
NadalD, BoniJ, KindC. Prospective evaluation of amplification-boosted ELISA for heat-denatured p24 antigen for diagnosis and monitoring of pediatric human immunodeficiency virus type 1 infection.J Infect Dis1999; 180: 1089–95
31.
SchupbachJ. Measurement of HIV-1 p24 antigen by signal-amplification-boosted ELISA of heat-denatured plasma is a simple and inexpensive alternative to tests for viral RNA.AIDS Rev2002; 4: 83–92
32.
PradoJG, ShintaniA, BofillM, ClotetB, RuizL, Martinez-PicadoJ. Lack of longitudinal intrapatient correlation between p24 antigenemia and levels of human immunodeficiency virus (HIV) type 1 RNA in patients with chronic HIV infection during structured treatment interruptions.J Clin Microbiol2004; 42: 1620–5
33.
BurgisserP, VernazzaP, FleppMPerformance of five different assays for the quantification of viral load in persons infected with various subtypes of HIV-1. Swiss HIV Cohort Study.J Acquir Immune Defic Syndr2000; 23: 138–44
